The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
Open accessAbstract
Human melanoma cells express relatively large amounts of the disialogangliosides GD3 and GD2 on their surface whereas neuroblastoma cells express GD2 as a major ganglioside. Monoclonal antibodies (Mabs) directed specifically to the carbohydrate moiety of GD3 and GD2 inhibit melanoma and neuroblastoma cell attachment to various substrate adhesive proteins, e.g. collagen, vitronectin, laminin, fibronectin, and a heptapeptide, glycyl-L-arginyl-glycyl-L-aspartyl-L-seryl-L-prolyl-L-cysteine, which constitutes the cell attachment site of fibronectin. Cells that are preattached to a fibronectin substrate can also be induced to detach and round up in the presence of purified anti-ganglioside Mab. Moreover, when melanoma cells that contain both GD2 and GD3 are incubated with Mabs directed to both of these molecules an additive inhibition is observed. The specificity of this inhibition is demonstrated since Mabs of various isotypes directed to either protein or carbohydrate epitopes on a number of other major melanoma or neuroblastoma cell surface antigens have no effect on cell attachment. A study of the kinetics involved in this inhibition indicates that significant effects occur during the first 5 min of cell attachment, suggesting an important role for GD2 and GD3 in the initial events of cell-substrate interactions. The role of gangliosides in cell attachment apparently does not directly involve a strong interaction with fibronectin since we could not observe any binding of radiolabeled fibronectin or fragments of the molecule known to contain the cell attachment site to melanoma gangliosides separated on thin-layer chromatograms. An alternative explanation would be that gangliosides may play a role in the electrostatic requirements for cell-substrate interactions. In this regard, controlled periodate oxidation of terminal, unsubstituted sialic acid residues on the cell surface not only specifically destroys the antigenic epitopes on GD2 and GD3 recognized by specific Mabs but also inhibits melanoma cell and neuroblastoma cell attachment. In fact, the periodate-induced ganglioside oxidation and the inhibition of cell attachment are equally dose dependent. These data suggest that cell-substratum interactions may depend in part on the electrostatic environment provided by terminal sialic acid residues of cell surface gangliosides and possibly other anionic glycoconjugates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
Self-citationCHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*
Svennerholm, L. (1963) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1963.tb08933.x · Cited by 1,643
Pytela, R., Pierschbacher, M. D., & Ruoslahti, E. (1985) · Cell · doi:10.1016/0092-8674(85)90322-8 · Cited by 1,101
Self-citationMagnani, J. L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., & Ginsburg, V (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45389-1 · Cited by 881
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.5985 · Cited by 681
Self-citationUse of a Monoclonal Antibody (W6/32) in Structural Studies of HLA-A,B,C Antigens
Parham, P., Barnstable, C. J., & Bodmer, W. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.1.342 · Cited by 673
Functional correlation between cell adhesive properties and some cell surface proteins.
Takeichi, M. (1977) · The Journal of cell biology · doi:10.1083/jcb.75.2.464 · Cited by 626
Glycosphingolipids as Tumor-Associated and Differentiation Markers 56
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.2.231 · Cited by 569
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
Bremer, E. G., Hakomori, S., Bowen-Pope, D. F., Raines, E., & Ross, R. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39801-0 · Cited by 499
Studies on the Chemical and Enzymatic Modification of Glycoproteins
Van Lenten, L., & Ashwell, G. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62392-0 · Cited by 488
Cited by
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
Self-citationCell Surface Receptors for Extracellular Matrix Molecules
Buck, C. A., & Horwitz, A. F. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.001143 · Cited by 789
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Cheresh, D. A., & Spiro, R. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45436-1 · Cited by 565
Self-citationCheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationNicolson, G. L. (1988) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00046483 · Cited by 502
Cheung, N. K., Lazarus, H., Miraldi, F. D., Abramowsky, C. R., Kallick, S., Saarinen, U. M., Spitzer, T., Strandjord, S. E., Coccia, P. F., & Berger, N. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1430 · Cited by 417
Nicolson, G. L. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90010-8 · Cited by 399
Fox, G., Parry, N. R., Barnett, P. V., McGinn, B., Rowlands, D. J., & Brown, F. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-3-625 · Cited by 389
Elices, M. J., & Hemler, M. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9906 · Cited by 378
Zimmerman, G. A., McIntyre, T. M., Mehra, M., & Prescott, S. M. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.2.529 · Cited by 374
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Nazha, B., Inal, C., & Owonikoko, T. K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01000 · Cited by 324
Emerging phagocytosis checkpoints in cancer immunotherapy
Liu, Y., Wang, Y., Yang, Y., Weng, L., Wu, Q., Zhang, J., Zhao, P., Fang, L., Shi, Y., & Wang, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01365-z · Cited by 275
McDonald, J. A., Quade, B. J., Broekelmann, T. J., LaChance, R., Forsman, K., Hasegawa, E., & Akiyama, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61453-x · Cited by 256
Okada, M., Itoh, M.-I., Haraguchi, M., Okajima, T., Inoue, M., Oishi, H., Matsuda, Y., Iwamoto, T., Kawano, T., Fukumoto, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100395200 · Cited by 179
Mcdonald, J. A. (1988) · The Molecular and Cellular Biology of Wound Repair · doi:10.1007/978-1-4615-1795-5_18 · Cited by 15
Metadata
- Authors
- Cheresh, D. A., Pierschbacher, M. D., Herzig, M. A., & Mujoo, K.
- Venue
- The Journal of cell biology
- Publisher
- Rockefeller University Press
- Published
- 1986-03-01
- Volume
- 102
- Issue
- 3
- Pages
- 688-696
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2153950787
- Cited by
- 313
- References
- 36
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.